Variant report

Variant	rs4808166
Chromosome Location	chr19:19078140-19078141
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr19:19051661..19053291-chr19:19076893..19078901,2	MCF-7	breast:
2	chr19:19050410..19053031-chr19:19077926..19082064,4	MCF-7	breast:

Variant related genes	Relation type
ENSG00000269019	Chromatin interaction
ENSG00000051128	Chromatin interaction

Extended variants
information (count: 8 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:2)

rs_ID	r²[population]
rs55728087	1.00[AMR][1000 genomes]
rs6511016	1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:6 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv911294	chr19:18872917-19093619	Active TSS Weak transcription Strong transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	43 gene(s)	inside rSNPs	diseases
2	nsv911298	chr19:18928480-19093619	Weak transcription Transcr. at gene 5' and 3' Enhancers Strong transcription Flanking Active TSS Bivalent Enhancer Active TSS ZNF genes & repeats Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	39 gene(s)	inside rSNPs	diseases
3	nsv911300	chr19:18944025-19093619	Genic enhancers Weak transcription Flanking Bivalent TSS/Enh Strong transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	38 gene(s)	inside rSNPs	diseases
4	nsv911302	chr19:18995201-19088981	Enhancers Genic enhancers Weak transcription Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	33 gene(s)	inside rSNPs	diseases
5	nsv833778	chr19:19012669-19201487	Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Strong transcription Genic enhancers Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	47 gene(s)	inside rSNPs	diseases
6	nsv2435	chr19:19077432-19122579	Strong transcription Bivalent Enhancer Enhancers Weak transcription Genic enhancers ZNF genes & repeats Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	14 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:27 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:19052600-19082800	Weak transcription	Right Atrium	heart
2	chr19:19073000-19078400	Weak transcription	HMEC	breast
3	chr19:19073200-19078200	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
4	chr19:19073200-19078200	Weak transcription	Fetal Thymus	thymus
5	chr19:19073200-19078400	Weak transcription	Spleen	Spleen
6	chr19:19074400-19078200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
7	chr19:19075200-19078200	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
8	chr19:19076800-19081600	Enhancers	Placenta	Placenta
9	chr19:19076800-19087200	Enhancers	Primary monocytes fromperipheralblood	blood
10	chr19:19077200-19078200	Enhancers	Primary neutrophils fromperipheralblood	blood
11	chr19:19077200-19078200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
12	chr19:19077200-19078400	Enhancers	HUES6 Cell Line	embryonic stem cell
13	chr19:19077200-19078400	Enhancers	iPS-15b Cell Line	embryonic stem cell
14	chr19:19077200-19078400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
15	chr19:19077200-19078800	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
16	chr19:19077200-19080800	Enhancers	Hela-S3	cervix
17	chr19:19077400-19078800	Enhancers	Primary hematopoietic stem cells short term culture	blood
18	chr19:19077400-19080400	Enhancers	Primary B cells from cord blood	blood
19	chr19:19077600-19078800	Enhancers	Primary hematopoietic stem cells	blood
20	chr19:19077600-19088800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
21	chr19:19077800-19078200	Weak transcription	Fetal Muscle Trunk	muscle
22	chr19:19078000-19078200	Enhancers	HepG2	liver
23	chr19:19078000-19078400	Enhancers	H9 Cell Line	embryonic stem cell
24	chr19:19078000-19078600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
25	chr19:19078000-19078800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
26	chr19:19078000-19078800	Enhancers	Adipose Nuclei	Adipose
27	chr19:19078000-19079000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links